John E. Leonard - 31 Mar 2023 Form 4 Insider Report for VACCINEX, INC. (VCNX)

Role: SVP, Development
Signature: /s/ Scott E. Royer, Attorney-in-Fact for John E. Leonard
Issuer symbol: VCNX
Transactions as of: 31 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 03 Apr 2023, 16:35:42 UTC
Previous filing: 04 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VCNX	Common Stock						2,258	31 Mar 2023	Direct
holding	VCNX	Common Stock						1,014	31 Mar 2023	By John Leonard Consulting, LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VCNX	Stock Option (Right to Buy)	Award	$0	+20,000		$0.000000	20,000	31 Mar 2023	Common Stock	20,000	$0.3995	Direct	F5
holding	VCNX	Stock Option (Right to Buy)						23,150	31 Mar 2023	Common Stock	23,150	$7.10	Direct	F1
holding	VCNX	Stock Option (Right to Buy)						3,062	31 Mar 2023	Common Stock	3,062	$7.10	Direct	F1
holding	VCNX	Stock Option (Right to Buy)						3,000	31 Mar 2023	Common Stock	3,000	$3.90	Direct	F1
holding	VCNX	Stock Option (Right to Buy)						4,000	31 Mar 2023	Common Stock	4,000	$6.07	Direct	F2
holding	VCNX	Stock Option (Right to Buy)						8,000	31 Mar 2023	Common Stock	8,000	$2.93	Direct	F3
holding	VCNX	Stock Option (Right to Buy)						16,000	31 Mar 2023	Common Stock	16,000	$1.29	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Exercisable in full as of the date of this report.
F2	This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the February 25, 2020 grant date.
F3	This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date.
F4	This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date.
F5	This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date.